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Background
Leptospirosis is a globally disseminated zoonosis, recog-
nized as a re-emergent neglected disease [1] and the cau-
sative pathogens are spirochetes from genus Leptospira
[2]. In Brazil, more than 100.00 leptospirosis cases are
reported annually, with outbreaks emerging especially dur-
ing floods [3]. The microscopic agglutination test (MAT)
is considered the standard serological test for the diagnosis
of leptospirosis, but it requires paired serum samples, is
demanding, difficult to analyse and the results can be vari-
able when compared between laboratories [2]. The
absence of an adequate laboratorial diagnosis is the main
barrier for the implementation of disease surveillance for
the control of both human and animal leptospirosis.
Hence, there is an urgent need for the development of an
adequate laboratorial test that is both quick and reliable.
Apart from the danger connected to rodents, which are
leptospires main vectors, occurrence of the disease in dogs
can generate a higher risk of infection for humans [4]. In
the current study, selected recombinant proteins from
L. interrogans were tested for their diagnostic potential
using a Dot-Blot technique against a canine serum panel
previously characterized by the MAT and a whole-cell
Leptospira indirect ELISA.
Methods
Nine recombinant proteins were tested for their ability of
recognize antibodies in Leptospirosis positive and negative
serum samples. The proteins were based on LigB, LigA,
OmpL37, LemA, FlaA1, FlaB1, and LipL32. Three differ-
ent concentrations were evaluated per antigen: 300, 500
and 1000 ng in each dot-blot. Two pooled serum dilutions
were tested: 1:200 and 1:500. Furthermore, two isotypes of
conjugated antibodies were evaluated: anti-dog IgG and
anti-dog IgM. Selected recombinant proteins were
screened using a panel of individual canine serum samples:
19 positive (11 vaccinated and 8 non-vaccinated) and 19
negative (11 vaccinated and 8 non-vaccinated). The degree
of reaction was classified in four levels of colour (-, +1, +2
and +3), where +2 and +3 were considered positives and -
and +1 negatives.
Results and conclusions
The majority of the tested antigens showed weak, non-
specific reactions with the positive sera, except for rLigBrep
and rLipL32. These recombinant proteins distinguished
between the positive and negative pooled sera. Using anti-
IgG, rLipL32 recognised all antigen concentrations at a
1:500 sera dilution. For rLigBrep, the best performance was
achieved with anti-IgM and 500 ng and 1000 ng of antigen,
regardless of the sera dilution. In an analysis of the indivi-
dual serum samples, the optimal concentration of rLigBrep
was 150 ng, and the sensitivity was 81.8% (9/11) and specifi-
city was 63.6% (7/11). Using serum samples from vacci-
nated animals, the rLigBrep had a sensitivity of 87.5% (7/8)
and specificity of 25% (2/8). rLipL32 failed to discriminate
between the positive and negative sera and was not
included in further evaluations. From these data, we can
conclude that the dot-blot technique showed promising
results in discriminating between positive and negative, vac-
cinated and non-vaccinated canine serum samples. How-
ever, further refinement of the technique is required before
it can be used for the diagnosis of canine leptospirosis.
Authors’ details
1Núcleo de Biotecnologia, CDTec, Universidade Federal de Pelotas, Pelotas,
Brazil. 2UniversidadeCatólica de Pelotas, Pelotas, Brazil.
Published: 1 October 2014
1Núcleo de Biotecnologia, CDTec, Universidade Federal de Pelotas, Pelotas,
Brazil
Full list of author information is available at the end of the article
Conra et al. BMC Proceedings 2014, 8(Suppl 4):P144
http://www.biomedcentral.com/1753-6561/8/S4/P144
© 2014 Conra et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
References
1. Hartskeerl RA, Collares-Pereira M, Ellis WA: Emergence, control and re-
emerging leptospirosis: dynamics of infection in the changing world.
Clin Microbiol Infect 2011, 17(4):494-501.
2. Mcbride AJ, Athanazio DA, Reis MG, Ko AI: Leptospirosis. Curr Opin Infect
Dis 2005, 18(5):376-86.
3. Levett PN: Leptospirosis. Clin Microbiol Rev 2001, 14(2):296-326.
4. Wasiński B, Dutkiewicz J: Leptospirosis–current risk factors connected
with human activity and the environment. Ann Agric Environ Med 2013,
20(2):239-44.
doi:10.1186/1753-6561-8-S4-P144
Cite this article as: Conra et al.: Development of a recombinant protein
based Dot-Blot for the diagnosis of canine leptospirosis. BMC
Proceedings 2014 8(Suppl 4):P144.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Conra et al. BMC Proceedings 2014, 8(Suppl 4):P144
http://www.biomedcentral.com/1753-6561/8/S4/P144
Page 2 of 2
